3(S)-acetoxy-5-(R)-hydroxy-cyclopent-1-ene | 60895-01-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3(S)-acetoxy-5-(R)-hydroxy-cyclopent-1-ene
• 英文别名: cis-4-cyclopentene-1,3-diol monoacetate；4-hydroxycyclopent-2-en-1-yl acetate；4-hydroxycyclopent-2-enyl acetate；3(R)-acetoxy-5(S)-hydroxycyclopent-1-ene；1-acetoxy-4-hydroxycyclopent-2-ene；4-hydroxy-2-cyclopentenyl acetate；(4-hydroxycyclopent-2-en-1-yl) acetate
• CAS: 60895-01-4；61348-01-4
• 化学式: C₇H₁₀O₃
• mdl: MFCD20488598
• 分子量: 142.155
• InChiKey: IJDYOKVVRXZCFD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3(S)-acetoxy-5-(R)-hydroxy-cyclopent-1-ene 在 palladium on activated charcoal 、 四(三苯基膦)钯 氢气 作用下， 以 四氢呋喃 为溶剂， 生成
  参考文献：
  名称：

  Palladium-catalyzed reaction of 4-cyclopentene-1,3-diol monoacetate with Grignard reagents producing hitherto unreachable cis-1,2-isomersElectronic supplementary information (ESI) available: typical procedure for the palladium-catalyzed reaction, determination of the structures and spectral data of products. See http://www.rsc.org/suppdata/cc/b3/b316596e/

  摘要：

  在钯催化剂存在下，4-环戊烯-1,3-二醇单乙酸酯与 RMgCl（R = 烷基、芳基）的反应在保留构型的情况下进行，主要产物为顺式-1,2-中间体异构体。

  DOI：

  10.1039/b316596e
• 作为产物：
  描述：

  4-acetoxy-cyclopentenone 在 cerium(III) chloride 、 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 以75%的产率得到3(S)-acetoxy-5-(R)-hydroxy-cyclopent-1-ene
  参考文献：
  名称：

  环戊烯酮醇的异常，选择性，还原性脱氧

  摘要：

  通过在甲醇中的NaBH 4 -CeCl 3选择性地进行2-芳基-4-羟基环戊-2-烯-1-酮的还原性脱氧反应，得到2-芳基-环戊-2-烯-1-酮。

  DOI：

  10.1016/j.tetlet.2014.07.122

文献信息

• PREPARATION OF LUBIPROSTONE
  申请人：Jackson Mark

  公开号：US20130184476A1

  公开（公告）日：2013-07-18

  Aspects of the present application relate to process for the preparation of lubiprostone.

  本申请涉及鲁比前列酮的制备过程。
• Method for producing allyl compound, and ether or ester compound produced thereby
  申请人：MITSUBISHI CHEMICAL CORPORATION

  公开号：US20040147757A1

  公开（公告）日：2004-07-29

  A method for producing an allyl compound having a compositional formula different from that of an allyl starting material compound, which comprises reacting the allyl starting material compound with an oxygen nucleophilic agent in the presence of a catalyst containing at least one transition metal compound containing a transition metal selected from the group consisting of transition metals belonging to Group 8 to Group 10 of the Periodic Table and a multidentate phosphite compound.

  一种生产具有与烯丙基起始物质化合物不同的组成式的烯丙基化合物的方法，包括在存在至少一种含有从周期表第8组到第10组的过渡金属属于的过渡金属的过渡金属化合物和多齿膦酸酯化合物的催化剂的情况下，将烯丙基起始物质化合物与氧亲核试剂反应。
• [EN] SUBSTITUTED ADENINES AND THE USE THEREOF<br/>[FR] ADENINES SUBSTITUEES ET LEUR UTILISATION
  申请人：ASTRAZENECA AB

  公开号：WO2006040558A1

  公开（公告）日：2006-04-20

  This invention relates to compounds of Formula (I): and their use in the treatment of bacterial infections.

  这项发明涉及式(I)的化合物及其在治疗细菌感染中的应用。
• TRPV1 Antagonists
  申请人：Gomtsyan Arthur

  公开号：US20120245163A1

  公开（公告）日：2012-09-27

  Disclosed herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates, or combinations thereof, wherein X 1 , X 2 , X 3 , X 4 , J, K, L, X 5 , X 6 , R b , G 2 , and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

  本文揭示了具有以下式（I）的化合物或药用可接受的盐、溶剂或其组合物，其中X1、X2、X3、X4、J、K、L、X5、X6、Rb、G2和m在规范中有定义。还披露了包含这些化合物的组合物以及使用这些化合物和组合物治疗疾病和疾病的方法。
• Cyclic ketones, their preparation and their use in the synthesis of amino acids
  申请人：——

  公开号：US20030187296A1

  公开（公告）日：2003-10-02

  A method is provided for making an enantiomerically pure of the formula: in which R and R′ represent C1?C10 alkyl, C2?C10 alkenyl or C3?C10 cycloalkyl and the wedges signify (S)- or (R)-stereochemistry, the substituents in compound (II) being trans. Conjugate addition is carried out between an organometallic nucleophile that provides a group R as defined above and (R)-4-acetoxycyclopent-2-en-1-one, (S)-4-acetoxycyclopent-2-en-1-one or a similar compound in which acetoxy is replaced by another leaving group to give, e.g. in the case of the acetoxy compound, a trans 3,4-disubstituted addition product of formula III or IV; The acetyl group is eliminated from the addition product to give an (R)- or (S)-4-alkyl or 4-alkenyl cyclopent-2-en-1-one the compound of formula is then to be hydrogenated to give a cyclopentanone of formula (I) or conjugate addition of a second organometallic nucleophile that provides a group R′ as defined above to the compound of the above formula may be carried out to give a trans 3,4-disubstituted addition product of formula (II). One of the above compounds may be converted e.g. via an intermediate (XV)-(XVIII) (in which the substituents R and R′ and the wedges have the meanings indicated above) to a gabapentin analogue of one of the formulae shown below: in which the substituents R and R′ and the wedges also have the meanings indicated above. 1 2

  提供一种制备公式的对映纯物质的方法：其中R和R′代表C1-C10烷基、C2-C10烯基或C3-C10环烷基，楔形符号表示(S)-或(R)-立体化学，化合物(II)中的取代基为反式。在有机金属亲核试剂和(R)-4-乙酰氧基环戊-2-烯-1-酮、(S)-4-乙酰氧基环戊-2-烯-1-酮或类似化合物之间进行共轭加成，其中乙酰氧基被另一个离去基取代，例如在乙酰氧基化合物的情况下，得到公式III或IV的反式3,4-二取代加成产物；从加成产物中消除乙酰基，得到(R)-或(S)-4-烷基或4-烯基环戊-2-烯-1-酮，然后将该化合物氢化，得到公式(I)的环戊酮，或者对上述公式的化合物进行第二次有机金属亲核试剂的共轭加成，得到公式(II)的反式3,4-二取代加成产物。上述化合物之一可以通过中间体(XV)-(XVIII)（其中取代基R和R′以及楔形符号具有上述所示的含义）转化为下面所示的公式之一的加巴喷丁类似物：其中取代基R和R′以及楔形符号也具有上述所示的含义。